Trial · NCT03536143
Results by group12
Each measurement the trial posted, group by group, in the words and numbers it posted.
1 to 12 of 12
Download this page as JSON| Outcome | Group | Category | Value | Spread | Units |
|---|---|---|---|---|---|
| Number of Subjects Reported at Least One Adverse Event, Safety Population | All Participants (Topical Beremagene Geperpavec (B-VEC), and Placebo) | 9 | Participants | ||
| Number of Adverse Events Reported, Safety Population | All Participants (Topical Beremagene Geperpavec (B-VEC), and Placebo) | 35 | number of adverse events | ||
| Complete Wound Closure Responder, ITT Population | B-VEC | Week 8 | 14 | number of responder | |
| Complete Wound Closure Responder, ITT Population | Placebo | Week 8 | 0 | number of responder | |
| Complete Wound Closure Responder, ITT Population | B-VEC | Week 10 | 12 | number of responder | |
| Complete Wound Closure Responder, ITT Population | Placebo | Week 10 | 2 | number of responder | |
| Complete Wound Closure Responder, ITT Population | B-VEC | Week 12 | 12 | number of responder | |
| Complete Wound Closure Responder, ITT Population | Placebo | Week 12 | 1 | number of responder | |
| Time to Wound Closure Analysis, ITT Population | Topical Beremagene Geperpavec | 13.5 | 95% Confidence Interval 8.0 to 21.0 | days | |
| Time to Wound Closure Analysis, ITT Population | Placebo | 22.5 | 95% Confidence Interval 8.0 to 64.0 | days | |
| Duration of Wound Closure, ITT Population | Topical Beremagene Geperpavec | 103.0 | 95% Confidence Interval 94.0 to 118.0 | days | |
| Duration of Wound Closure, ITT Population | Placebo | 16.5 | 95% Confidence Interval 0.0 to 66.0 | days |
Source ClinicalTrials.govtrials-2026-11-12-0.5.0
Sources 3
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ClinicalTrials.govNo license stated
- NIH RePORTER's clinical studies and project filesPublic domain
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ClinicalTrials.govnone stated
- NIH RePORTER's clinical studies and project filesPublic domain (NIH RePORTER)
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/trials/v1/NCT03536143/results